Anx-131 -

Many modern cancer drugs work by inhibiting kinases—enzymes that act as switches for cell growth. The structure of ANX-131 aligns well with the ATP-binding pockets common to many kinases. Researchers are currently exploring derivatives of ANX-131 as selective inhibitors for hard-to-target cancers, potentially offering treatments for tumors that have developed resistance to first-generation therapies.

In the medical and pharmaceutical fields, "ANX-131" (and its variants like or ABSK131 ) often serves as a candidate name for new drugs or therapeutic protocols. ANX-131

The Blood-Brain Barrier (BBB) remains one of the most formidable obstacles in treating neurological diseases. Because fragments like ANX-131 are small and efficient, they often possess physicochemical properties (low molecular weight, moderate lipophilicity) conducive to crossing the BBB. This opens the door for researching ANX-131 derivatives in the treatment of Alzheimer’s, Parkinson’s, or rare genetic neurological conditions. In the medical and pharmaceutical fields, "ANX-131" (and

In the United States, "I-131" is synonymous with the issued by the USCIS. This is a vital document for non-citizens residing in the U.S. who need to travel abroad without losing their status. This opens the door for researching ANX-131 derivatives